Our 'In Profile' feature examines some of the biggest players in the industry and their journey into pharma. Here, we sit down with Ettore Cucchetti, CEO of ACG Inspection at ACG, who discusses the success of a major company milestone, and the challenges and opportunities serialisation presents.
In Profile
How did you get into the pharma industry?
I first entered the pharma industry in 2015 when I started with ACG. I was head hunted whilst working for a technology company in Switzerland, so it meant a transfer to Mumbai in India.
I have always focused on technology, mainly around quality and regulation, so moving into inspections in the pharma industry was a natural and appropriate progression. Whilst traceability as a topic within the industry goes back to the 1980/90s, and we have also seen the evolution of tracing from analogue to digital, pharma is certainly behind other industries when it comes to using tech. Being at the forefront of new technologies and innovations is what really attracted me to working in this industry and to this role at ACG.